APO RESEARCH · REPORT
Transcatheter Aortic Valve Replacement (TAVR)
Transcatheter Aortic Valve Replacement (TAVR), also referred as Transcatheter Aortic Valve Implantation (TAVI) is a minimally invasive surgical procedure repairs the valve without removing the old, damaged valve. Instead, it wedges a replacement valve into the aortic valve's place. Normally valve replacement method requires an open heart procedure with a sternotomy, in which the chest is surgically separated for the treatment. The TAVR procedures can be done through very small openings that leave all the chest bones in place.
Product & engineering
Understand the product.
Transcatheter Aortic Valve Replacement (TAVR), also referred as Transcatheter Aortic Valve Implantation (TAVI) is a minimally invasive surgical procedure repairs the valve without removing the old, damaged valve. Instead, it wedges a replacement valve into the aortic valve's place. Normally valve replacement method requires an open heart procedure with a sternotomy, in which the chest is surgically separated for the treatment. The TAVR procedures can be done through very small openings that leave all the chest bones in place.
Selected research
Industry Growth & Trends
Global Transcatheter Aortic Valve Replacement (TAVR) Industry Growth and Trends Forecast to 2032
Market perspective
Transcatheter Aortic Valve Replacement (TAVR), also referred as Transcatheter Aortic Valve Implantation (TAVI) is a minimally invasive surgical procedure repairs the valve without removing the old, damaged valve. Instead, it wedges a replacement valve into the aortic valve's place. Normally valve replacement method requires an open heart procedure with a sternotomy, in which the chest is surgically separated for the treatment. The TAVR procedures can be done through very small openings that leave all the chest bones in place.
According to APO Research, the global Transcatheter Aortic Valve Replacement (TAVR) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global Transcatheter Aortic Valve Replacement (TAVR) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Transcatheter Aortic Valve Replacement (TAVR) market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Transcatheter Aortic Valve Replacement (TAVR) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Transcatheter Aortic Valve Replacement (TAVR).
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Transcatheter Aortic Valve Replacement (TAVR) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Transcatheter Aortic Valve Replacement (TAVR) Market by Company
Edwards Lifesciences
Medtronic
Abbott
Boston Scientific
Meril Life Sciences
Venus Medtech
Bracco (HLT)
JenaValve Technology
Suzhou Jiecheng Medical Technology Co.
Peijia Medical
Transcatheter Aortic Valve Replacement (TAVR) Segment by Type
Transfemoral Approach
Transapical Approach
Others
Transcatheter Aortic Valve Replacement (TAVR) Segment by Application
Aortic Stenosis
Aortic Regurgitation
Others
Transcatheter Aortic Valve Replacement (TAVR) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transcatheter Aortic Valve Replacement (TAVR) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Transcatheter Aortic Valve Replacement (TAVR) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transcatheter Aortic Valve Replacement (TAVR).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Transcatheter Aortic Valve Replacement (TAVR) companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Transfemoral Approach
- Transapical Approach
- Others
Applications
- Aortic Stenosis
- Aortic Regurgitation
- Others
Companies covered
- Edwards Lifesciences
- Medtronic
- Abbott
- Boston Scientific
- Meril Life Sciences
- Venus Medtech
- Bracco (HLT)
- JenaValve Technology
- Suzhou Jiecheng Medical Technology Co.
- Peijia Medical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Transcatheter Aortic Valve Replacement (TAVR) Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Transcatheter Aortic Valve Replacement (TAVR) Market Size by Region (2021-2032)
- 1.4.1 Global Transcatheter Aortic Valve Replacement (TAVR) Market Size by Region (2021-2026)
- 1.4.2 Global Transcatheter Aortic Valve Replacement (TAVR) Market Size by Region (2027-2032)
- 1.5 Key Regions Transcatheter Aortic Valve Replacement (TAVR) Market Size (2021-2032)
- 1.5.1 North America Transcatheter Aortic Valve Replacement (TAVR) Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Transcatheter Aortic Valve Replacement (TAVR) Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Market Size Growth Rate (2021-2032)
- 1.5.4 South America Transcatheter Aortic Valve Replacement (TAVR) Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Transcatheter Aortic Valve Replacement (TAVR) Market Size Growth Rate (2021-2032)
2 Transcatheter Aortic Valve Replacement (TAVR) Market by Type
- 2.1 Type Introduction
- 2.1.1 Transfemoral Approach
- 2.1.2 Transapical Approach
- 2.1.3 Others
- 2.2 Global Transcatheter Aortic Valve Replacement (TAVR) Market Size by Type
- 2.2.1 Global Transcatheter Aortic Valve Replacement (TAVR) Market Size Overview by Type (2021-2032)
- 2.2.2 Global Transcatheter Aortic Valve Replacement (TAVR) Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Transcatheter Aortic Valve Replacement (TAVR) Market Size Forecasted by Type (2027-2032)
- 2.3 Global Transcatheter Aortic Valve Replacement (TAVR) Market Size by Regions
- 2.3.1 North America Transcatheter Aortic Valve Replacement (TAVR) Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Transcatheter Aortic Valve Replacement (TAVR) Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Transcatheter Aortic Valve Replacement (TAVR) Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Transcatheter Aortic Valve Replacement (TAVR) Market Size Breakdown by Type (2021-2026)
3 Transcatheter Aortic Valve Replacement (TAVR) Market by Application
- 3.1 Type Introduction
- 3.1.1 Aortic Stenosis
- 3.1.2 Aortic Regurgitation
- 3.1.3 Others
- 3.2 Global Transcatheter Aortic Valve Replacement (TAVR) Market Size by Application
- 3.2.1 Global Transcatheter Aortic Valve Replacement (TAVR) Market Size Overview by Application (2021-2032)
- 3.2.2 Global Transcatheter Aortic Valve Replacement (TAVR) Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Transcatheter Aortic Valve Replacement (TAVR) Market Size Forecasted by Application (2027-2032)
- 3.3 Global Transcatheter Aortic Valve Replacement (TAVR) Market Size by Regions
- 3.3.1 North America Transcatheter Aortic Valve Replacement (TAVR) Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Transcatheter Aortic Valve Replacement (TAVR) Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Transcatheter Aortic Valve Replacement (TAVR) Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Transcatheter Aortic Valve Replacement (TAVR) Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Transcatheter Aortic Valve Replacement (TAVR) Industry Trends
- 4.2 Transcatheter Aortic Valve Replacement (TAVR) Industry Drivers
- 4.3 Transcatheter Aortic Valve Replacement (TAVR) Industry Opportunities and Challenges
- 4.4 Transcatheter Aortic Valve Replacement (TAVR) Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Transcatheter Aortic Valve Replacement (TAVR) Revenue (2021-2026)
- 5.2 Global Transcatheter Aortic Valve Replacement (TAVR) Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Transcatheter Aortic Valve Replacement (TAVR) Key Company Headquarters & Area Served
- 5.4 Global Transcatheter Aortic Valve Replacement (TAVR) Company, Product Type & Application
- 5.5 Global Transcatheter Aortic Valve Replacement (TAVR) Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Transcatheter Aortic Valve Replacement (TAVR) Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Transcatheter Aortic Valve Replacement (TAVR) Players Market Share by Revenue in 2025
- 5.6.3 2025 Transcatheter Aortic Valve Replacement (TAVR) Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Edwards Lifesciences
- 6.1.1 Edwards Lifesciences Company Information
- 6.1.2 Edwards Lifesciences Business Overview
- 6.1.3 Edwards Lifesciences Transcatheter Aortic Valve Replacement (TAVR) Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Edwards Lifesciences Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
- 6.1.5 Edwards Lifesciences Recent Developments
- 6.2 Medtronic
- 6.2.1 Medtronic Company Information
- 6.2.2 Medtronic Business Overview
- 6.2.3 Medtronic Transcatheter Aortic Valve Replacement (TAVR) Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Medtronic Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
- 6.2.5 Medtronic Recent Developments
- 6.3 Abbott
- 6.3.1 Abbott Company Information
- 6.3.2 Abbott Business Overview
- 6.3.3 Abbott Transcatheter Aortic Valve Replacement (TAVR) Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Abbott Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
- 6.3.5 Abbott Recent Developments
- 6.4 Boston Scientific
- 6.4.1 Boston Scientific Company Information
- 6.4.2 Boston Scientific Business Overview
- 6.4.3 Boston Scientific Transcatheter Aortic Valve Replacement (TAVR) Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Boston Scientific Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
- 6.4.5 Boston Scientific Recent Developments
- 6.5 Meril Life Sciences
- 6.5.1 Meril Life Sciences Company Information
- 6.5.2 Meril Life Sciences Business Overview
- 6.5.3 Meril Life Sciences Transcatheter Aortic Valve Replacement (TAVR) Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Meril Life Sciences Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
- 6.5.5 Meril Life Sciences Recent Developments
- 6.6 Venus Medtech
- 6.6.1 Venus Medtech Company Information
- 6.6.2 Venus Medtech Business Overview
- 6.6.3 Venus Medtech Transcatheter Aortic Valve Replacement (TAVR) Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Venus Medtech Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
- 6.6.5 Venus Medtech Recent Developments
- 6.7 Bracco (HLT)
- 6.7.1 Bracco (HLT) Company Information
- 6.7.2 Bracco (HLT) Business Overview
- 6.7.3 Bracco (HLT) Transcatheter Aortic Valve Replacement (TAVR) Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Bracco (HLT) Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
- 6.7.5 Bracco (HLT) Recent Developments
- 6.8 JenaValve Technology
- 6.8.1 JenaValve Technology Company Information
- 6.8.2 JenaValve Technology Business Overview
- 6.8.3 JenaValve Technology Transcatheter Aortic Valve Replacement (TAVR) Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 JenaValve Technology Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
- 6.8.5 JenaValve Technology Recent Developments
- 6.9 Suzhou Jiecheng Medical Technology Co.
- 6.9.1 Suzhou Jiecheng Medical Technology Co. Company Information
- 6.9.2 Suzhou Jiecheng Medical Technology Co. Business Overview
- 6.9.3 Suzhou Jiecheng Medical Technology Co. Transcatheter Aortic Valve Replacement (TAVR) Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Suzhou Jiecheng Medical Technology Co. Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
- 6.9.5 Suzhou Jiecheng Medical Technology Co. Recent Developments
- 6.10 Peijia Medical
- 6.10.1 Peijia Medical Company Information
- 6.10.2 Peijia Medical Business Overview
- 6.10.3 Peijia Medical Transcatheter Aortic Valve Replacement (TAVR) Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Peijia Medical Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
- 6.10.5 Peijia Medical Recent Developments
7 North America
- 7.1 North America Transcatheter Aortic Valve Replacement (TAVR) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Transcatheter Aortic Valve Replacement (TAVR) Market Size by Country (2021-2026)
- 7.3 North America Transcatheter Aortic Valve Replacement (TAVR) Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Transcatheter Aortic Valve Replacement (TAVR) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Transcatheter Aortic Valve Replacement (TAVR) Market Size by Country (2021-2026)
- 8.3 Europe Transcatheter Aortic Valve Replacement (TAVR) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Transcatheter Aortic Valve Replacement (TAVR) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Transcatheter Aortic Valve Replacement (TAVR) Market Size by Country (2021-2026)
- 10.3 South America Transcatheter Aortic Valve Replacement (TAVR) Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Transcatheter Aortic Valve Replacement (TAVR) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Transcatheter Aortic Valve Replacement (TAVR) Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Transcatheter Aortic Valve Replacement (TAVR) Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst